Financial News

Nicox: 2019 Ordinary Shareholder Meeting postponed to June 19, 2019

Sophia Antipolis, France
Nicox SA (Euronext Paris: FR0013018124, COX), an international ophthalmology company, informs its shareholders that the ordinary general meeting convened on first call on June 4, 2019, cannot be held as the quorum required by law will not be reached.
The shareholders are thus convened on second call for an ordinary general meeting on the same agenda on Wednesday June 19,

Read more

Nicox Presents First Data on Promising New Class of Nitric Oxide (NO)-Donating Compounds for Glaucoma at the ARVO 2019 Annual Meeting

  • Nitric oxide (NO)-donating phosphodiesterase-5 (PDE5) inhibitors constitute new drug class for patients with glaucoma
  • Lead molecule substantially and sustainably lowers intraocular pressure (IOP) in non-human primate model of ocular hypertension
  • Potential for development as adjunctive therapy or in fixed-dose combinations with latanoprost or other prostaglandin analogs (PGAs) for lowering IOP in patients with glaucoma or ocular hypertension

Nicox SA (Euronext Paris: FR0013018124,

Read more
More news
Press releases
More press releases